Sucampo Completes Acquisition of R-Tech Ueno

Go back to Sucampo Completes Acquisition of R-Tech Ueno

Sucampo Pharma (SCMP) Announces Completion of $275M R-Tech Ueno Acquisition

December 7, 2015 6:50 AM UTC

Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) announced the completion of its acquisition of R-Tech Ueno (TSE:4573:JP) and all remaining outstanding shares. Sucampo acquired R-Tech Ueno for 32.8 billion Japanese Yen (JPY), or approximately $275 million.

"We believe that, through this immediately accretive transaction, we've created value for our shareholders by positioning ourselves for revenue growth in the near-term and laying the groundwork for continued financial performance in the future," said Peter Greenleaf, Chief Executive Officer of Sucampo. "We have now secured a larger portion of the global economics of AMITIZA® and greater control over the... More